Harbour Investments’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-34
Closed -$1K 4135
2021
Q2
$1K Buy
34
+9
+36% +$177 ﹤0.01% 3726
2021
Q1
$0 Buy
+25
New +$570 ﹤0.01% 3791

Harbour Investments's TBIO Position: Q3 2021 in Review

Harbour Investments sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 34 shares — an estimated $1K sold.

Harbour Investments first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Harbour Investments reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Harbour Investments sold 34 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Harbour Investments first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Harbour Investments's Translate Bio, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Harbour Investments's 13F filing for Q3 2021, filed 15 Nov 2021.